NCT07728669

Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-07-20Est. Completion: 2026-11

Enrollment target: 120 participants

Locations

Contact

Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…

Multiple LocationsEst. completion Jan 12, 2027

Non-alcoholic Fatty Liver Disease

The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis…

Chandler, United StatesEst. completion Mar 29, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.